DELLAVEDOVA, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 93
AS - Asia 65
NA - Nord America 40
SA - Sud America 6
AF - Africa 2
OC - Oceania 1
Totale 207
Nazione #
US - Stati Uniti d'America 40
RU - Federazione Russa 27
IT - Italia 25
SG - Singapore 19
HK - Hong Kong 17
CN - Cina 13
IE - Irlanda 12
DE - Germania 7
FI - Finlandia 6
IN - India 6
GB - Regno Unito 5
KR - Corea 5
NL - Olanda 5
BR - Brasile 4
FR - Francia 3
EG - Egitto 2
TW - Taiwan 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
DK - Danimarca 1
JP - Giappone 1
TM - Turkmenistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 207
Città #
Hong Kong 17
Dublin 11
Milan 10
Singapore 9
Los Angeles 5
Helsinki 4
Shanghai 4
Nuremberg 3
Santa Clara 3
Turin 3
Bergamo 2
Boston 2
Cairo 2
Chengdu 2
Frankfurt am Main 2
Hyderabad 2
Lappeenranta 2
Manchester 2
Moscow 2
New York 2
Orléans 2
Perugia 2
Rotterdam 2
San Francisco 2
Santa Cruz 2
Seoul 2
Yeonsu-gu 2
Araras 1
Ashburn 1
Ashgabat 1
Bari 1
Bethesda 1
Chongqing 1
Council Bluffs 1
Dallas 1
Delhi 1
Desio 1
Dietikon 1
Dongguan 1
Düsseldorf 1
Frederiksberg 1
Jequié 1
Kochi 1
Macaé 1
Maracaibo 1
Mediglia 1
Melzo 1
Peterborough 1
Pindamonhangaba 1
Portsmouth 1
Potomac 1
Romola 1
San Juan Bautista 1
San Marcos 1
Tokyo 1
Wuhan 1
Totale 132
Nome #
STRATEGIES TO OVERCOME OLAPARIB DRAWBACKS: FROM PATIENT SELECTION TO NOVEL THERAPIES 95
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin 49
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases 44
The next generation PARP inhibitor AZD5305 is active in a broad range of pre-clinical models of ovarian cancer 33
Totale 221
Categoria #
all - tutte 1.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024103 0 0 0 15 5 6 7 36 4 15 7 8
2024/2025118 9 13 5 7 14 6 16 7 15 26 0 0
Totale 221